LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 36 filers reported holding LUMOS PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,374,611 | +29.4% | 416,549 | +29.4% | 0.00% | – |
| Q2 2023 | $1,062,233 | -0.3% | 321,889 | +0.0% | 0.00% | – |
| Q1 2023 | $1,065,452 | -7.3% | 321,888 | +1.2% | 0.00% | – |
| Q4 2022 | $1,148,774 | -60.2% | 318,220 | -2.5% | 0.00% | -100.0% |
| Q3 2022 | $2,888,000 | +17.7% | 326,315 | +2.4% | 0.00% | 0.0% |
| Q2 2022 | $2,453,000 | -18.0% | 318,576 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $2,991,000 | +36.6% | 318,202 | +0.7% | 0.00% | 0.0% |
| Q4 2021 | $2,190,000 | -27.4% | 315,973 | -0.4% | 0.00% | 0.0% |
| Q3 2021 | $3,016,000 | +39.7% | 317,185 | +46.9% | 0.00% | – |
| Q2 2021 | $2,159,000 | +11.1% | 215,958 | +30.0% | 0.00% | – |
| Q1 2021 | $1,943,000 | -53.8% | 166,085 | +41.2% | 0.00% | -100.0% |
| Q4 2020 | $4,202,000 | +161.3% | 117,660 | +1.1% | 0.00% | – |
| Q3 2020 | $1,608,000 | -13.1% | 116,392 | +3.7% | 0.00% | -100.0% |
| Q2 2020 | $1,850,000 | +687.2% | 112,202 | +304.6% | 0.00% | – |
| Q1 2020 | $235,000 | – | 27,733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acuitas Investments, LLC | 125,242 | $413,299 | 0.24% |
| Lion Point Capital, LP | 90,794 | $299,620 | 0.13% |
| Greenwich Wealth Management LLC | 76,341 | $252 | 0.03% |
| Wealth Advisors of Iowa, LLC | 11,699 | $38,606 | 0.03% |
| Marquette Asset Management, LLC | 25,760 | $85,008 | 0.02% |
| Key FInancial Inc | 10,927 | $36,059 | 0.01% |
| Paladin Advisory Group, LLC | 4,387 | $14,477 | 0.01% |
| Blackstone Inc. | 468,145 | $1,544,879 | 0.01% |
| Leucadia National | 120,651 | $398,148 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $157,222 | 0.00% |